期刊文献+

10年宫颈腺癌住院患者发病趋势及临床特点分析 被引量:13

Incidence Trend and Clinical Characteristic Changes of Inpatients with Cervical Adenocarcinoma in the Last Decade
在线阅读 下载PDF
导出
摘要 目的:探讨10年来宫颈腺癌住院患者发病趋势及临床特点。方法:2006年1月至2016年5月北京大学第一医院确诊为宫颈腺癌并符合研究标准的住院患者99例,回顾性分析诊断途径、肿瘤分期及细胞学、病毒筛查情况等临床特点。结果:(1)近10年腺癌的发病比例呈现上升的趋势,不同时期宫颈腺癌临床分期差异有统计学意义(P<0.05)。(2)宫颈腺癌排在前3位的临床症状为阴道不规则流血、性生活后阴道流血、阴道分泌物异常,分别占37.37%(37例)、34.34%(34例)和8.08%(8例)。症状就诊组与体检就诊组比较后发现,宫颈腺癌临床分期、肿块直径、肌层浸润程度差异有统计学意义(P<0.05),而分化程度、病理类型、淋巴结转移、手术切缘等比较差异无统计学意义(P>0.05)。(3)宫颈腺癌细胞学筛查仍以鳞状细胞改变为主(42.19%),HPV检测中最常见型别为HPV18,占36.21%(21/58),17例(29.31%)HPV检测阴性。HPV阴性患者与阳性患者比较,宫颈腺癌肿块直径、肌层浸润及脉管癌栓差异有统计学意义(P<0.05),而发病年龄、病理类型、分化程度、临床分期、手术切缘及淋巴结转移比较差异无统计学意义(P>0.05)。结论:宫颈腺癌发生率逐年上升,但部分宫颈腺癌患者在筛查中表现为细胞学及HPV阴性,容易被漏诊,应提高对宫颈腺癌患者筛查的关注。 Objective:To evaluate the incidence trend and clinical characteristic changes of inpatients with cervical adenocarcinoma in the last decade. Methods :A retrospective analysis was performed. 99 patients diagnosed with adenocarcinoma of cervix and hospitalized at Peking University First Hospital(PUFH) from January 2006 to May 2016 were included. Patients were divided into two groups according to the year and the results of screening. The clinical characteristics including basic information, diagnostic way and cancer stage were recorded and analysed. Results.①The incidence ratio of cervical adenocarcinoma had been significantly increased in the last decade,while clinical stage was statistically different. ②The top three symptoms of cervical adenocarcinoma were irregular vaginal bleeding,bleeding after intercourse, abnormal vaginal discharge, accounting for 37.37% ,34.34% and 8.08%, respectively. There were significant differences in the stage of cervical cancer and the diameter of the lesion( P 〈 0.05) after the comparison between the symptomatic group and the asymptomatic group, but there were no differences in differentiation degree, pathological type, lymph node metastasis and resection margin. Cytological screening of cervical adenocarcinoma was still dominated by squamous cell changes (42. 19%). HPV18 ranked first in HPV detection,accounting for 36.21% (21/58) ,however,29.31% cases were negative in HPV test. There was no significant difference in the age, pathological type, differentiation degree, resection margin and lymph node metastasis between HPV negative and positive patients with cervical adenocarcinoma (P 〉 0.05). Conclusions: The incidence of cervical adenocarcinoma is increasing year by year. Some patients with cervical adenecarcinema have negative screening results for cytology and HPV, easy to be missed diagnosis, therefore,more attention should be put into the screening for cervical adenocarcinoma in order to find the cancer earlier.
作者 张婧 陶霞
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2017年第11期838-843,共6页 Journal of Practical Obstetrics and Gynecology
关键词 宫颈腺癌 发病趋势 细胞学筛查 人乳头瘤病毒 Cervical adenocarcinoma Incidence trend Cytological screening Human papilloma virus
  • 相关文献

参考文献3

二级参考文献29

  • 1李华,章文华,张蓉,吴令英,李晓光,白萍.子宫颈腺癌159例预后影响因素分析[J].中华妇产科杂志,2005,40(4):235-238. 被引量:19
  • 2张江宇,赖日权,张佳立,吴坤河,彭秀红,郜红艺,何平花.宫颈液基细胞学涂片假阴性原因分析[J].临床与实验病理学杂志,2005,21(6):663-665. 被引量:29
  • 3Missaoui N, Trabelsi A, Landolsi H, et al. Cervical adenocarci- noma and squamous cell carcinoma incidence trends among Tunisian women [J]. Asian Pacific journal of cancer prevention: APJCP, 2010, 11 (3): 777-780.
  • 4Bulk S, Visser O, Rozendaal L, et al. Cervical cancer in the Netherlands 1989-1998 : Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women [J ]. IntJCancer, 2005, 113 (6): 1005-1009.
  • 5Baalbergen A, Ewing-Graham PC, Hop WC, et al. Prognostic factors in adenocarcinoma of the uterine cervix[J. Gynecol Oncol, 2004, 92 ( 1 ) : 262-267.
  • 6Castellsagu X, Dlaz M, de Sanjos S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofac- tors: implications for screening and prevention [J. J Natl Cancer Inst, 2006, 98 (5): 303-315.
  • 7Gien LT, Beauchemin MC, Thomas G. Adenocarcinoma: a u- nique cervical Cancer[J]. Gynecol Oncol, 2010, 116 (1) : 140- 146.
  • 8Howlett RI, Marrett LD, Innes MK, et al. Decreasing incidence of cervical adenocarcinoma in Ontario: is this related to improved endocervical Pap test sampling [J]. Int J Cancer, 2007, 120 (2) : 362-367.
  • 9Davey DD. Cervical cytology classification and the Bethesda Systam. Cancer J, 2003, 9(5): 327-334.
  • 10马景丽,王金桃,丁玲,郝敏.薄层液基细胞学技术对宫颈疾病诊断价值评价[J].实用预防医学,2007,14(6):1724-1726. 被引量:8

共引文献38

同被引文献115

引证文献13

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部